NextCure (NXTC) Other Non-Current Assets (2018 - 2026)
NextCure (NXTC) reported Other Non-Current Assets of $82,000 for Q2 2026, down 85.2% from $555,000 a year earlier and down 90.3% from the prior quarter.
NextCure (NXTC) Other Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, NextCure posted Other Non-Current Assets of $546,000, up 64.5% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of -28.2% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $332,000 in FY2024 (-82.4%), $1.88 million in FY2023 (-42.4%), $3.27 million in FY2022 (+465.9%) and $577,000 in FY2021 (-79.8%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets in data going back to Q4 2018.
- Year over year, Other Non-Current Assets gained in two of the last eight quarters, with an average decline of 24.8%.
- The high point for year-over-year Other Non-Current Assets in five years was Q4 2022 (growth of 465.9%); the low point was Q2 2026 (a decline of 85.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $847,000 (Q1 2026), $546,000 (Q4 2025) and $550,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | NextCure | 29.52 Mn | -91.24 Mn | - | 82,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82,000.00 |
| Mar 31, 2026 | 847,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Sep 30, 2025 | 550,000.00 |
| Jun 30, 2025 | 555,000.00 |
| Mar 31, 2025 | 328,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Sep 30, 2023 | 2.85 Mn |
| Jun 30, 2023 | 2.86 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 2.47 Mn |
| Jun 30, 2022 | 801,000.00 |
| Mar 31, 2022 | 574,000.00 |
| Dec 31, 2021 | 577,000.00 |
| Sep 30, 2021 | 581,000.00 |
NextCure Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();